Easyomics platform is an integrated data analysis system that simplifies the entire metabolomics analysis process, from initial sample preparation to final data analysis. Easyomics consists of multiple consumable components that eliminate difficult and complex sample preparation steps, pre-conditioned columns that enable rapid chromatographic separation of target metabolites, standardized quantitative analysis kits that produce reliable measurements of these analytes, and software tools that allow the resulting data to be easily interpreted.

Our products address an urgent need in the metabolomic analytics market for tools that simplify exceedingly complex metabolomics workflows and make them accessible to users with minimal technical expertise.  This unmet segment of the market is currently devoid of competition, despite increasing demand for cost-effective solutions that accelerate laboratory diagnostic timelines. Fluidome’s products offer clients a distinct competitive edge as they will:

•  Decrease costs compared to traditional metabolomics workflows consumable material and overall cost of rapid diagnostic platforms

•  provide easy experimental procedures, that can be done by technical staff without specific training,

•  Shrink workflows from complex multi-step procedures into a single step for rapid development from concept to commercialization

•  Compatible with conventional LC-MS/MS instrumentation and built for automation

These features make Fluidome Inc.’s products highly attractive to large-volume, high-throughput users such as diagnostic laboratories, hospitals, environmental sampling firms, and academic research institutes.

Our solution for COVID-19

A biohazard viral containment device (VCDTM) has been invented in Fluidome that allows biohazard, such as viruses or microbes, to be live-cultured, for example, for amplification, drug testing, and other core research while being safely contained. The device, therefore, enables detailed biochemical analyses of microbes and viruses while minimizing exposure risks to laboratory personnel. As such, the VCDTM can permit biohazard research, which would normally be restricted to BSL3 laboratories, to occur in a standard biosafety level 2 (BSL2) laboratory. Of course, the device has applications for other less hazardous research as well; for example, some individuals may want to use this system to contain BSL2 organisms in a BSL1 environment, or perhaps just to provide an additional level of safety for staff.”